These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19665685)

  • 1. Quantum dot-based HIV capture and imaging in a microfluidic channel.
    Kim YG; Moon S; Kuritzkes DR; Demirci U
    Biosens Bioelectron; 2009 Sep; 25(1):253-8. PubMed ID: 19665685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient on-chip isolation of HIV subtypes.
    Wang S; Esfahani M; Gurkan UA; Inci F; Kuritzkes DR; Demirci U
    Lab Chip; 2012 Apr; 12(8):1508-15. PubMed ID: 22391989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic chips designed for measuring biomolecules through a microbead-based quantum dot fluorescence assay.
    Yun KS; Lee D; Kim HS; Yoon E
    Methods Mol Biol; 2009; 544():53-67. PubMed ID: 19488693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-capture and in situ detection of Salmonella typhimurium on a novel microfluidic chip.
    Wang R; Ni Y; Xu Y; Jiang Y; Dong C; Chuan N
    Anal Chim Acta; 2015 Jan; 853():710-717. PubMed ID: 25467522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.
    Stamatos NM; Mascola JR; Kalyanaraman VS; Louder MK; Frampton LM; Birx DL; VanCott TC
    J Virol; 1998 Dec; 72(12):9656-67. PubMed ID: 9811699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergence of quantum dot barcodes with microfluidics and signal processing for multiplexed high-throughput infectious disease diagnostics.
    Klostranec JM; Xiang Q; Farcas GA; Lee JA; Rhee A; Lafferty EI; Perrault SD; Kain KC; Chan WC
    Nano Lett; 2007 Sep; 7(9):2812-8. PubMed ID: 17705551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
    Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
    J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.
    Arthur LO; Bess JW; Waters DJ; Pyle SW; Kelliher JC; Nara PL; Krohn K; Robey WG; Langlois AJ; Gallo RC
    J Virol; 1989 Dec; 63(12):5046-53. PubMed ID: 2555541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.
    Ashokkumar M; Aralaguppe SG; Tripathy SP; Hanna LE; Neogi U
    J Virol; 2018 May; 92(9):. PubMed ID: 29491151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An amorphous silicon photodiode microfluidic chip to detect nanomolar quantities of HIV-1 virion infectivity factor.
    Vistas CR; Soares SS; Rodrigues RM; Chu V; Conde JP; Ferreira GN
    Analyst; 2014 Aug; 139(15):3709-13. PubMed ID: 24922601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration and purification of human immunodeficiency virus type 1 virions by microfluidic separation of superparamagnetic nanoparticles.
    Chen GD; Alberts CJ; Rodriguez W; Toner M
    Anal Chem; 2010 Jan; 82(2):723-8. PubMed ID: 19954210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
    Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
    J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys.
    Etemad-Moghadam B; Karlsson GB; Halloran M; Sun Y; Schenten D; Fernandes M; Letvin NL; Sodroski J
    J Virol; 1998 Oct; 72(10):8437-45. PubMed ID: 9733899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
    McCaffrey RA; Saunders C; Hensel M; Stamatatos L
    J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.
    Raska M; Takahashi K; Czernekova L; Zachova K; Hall S; Moldoveanu Z; Elliott MC; Wilson L; Brown R; Jancova D; Barnes S; Vrbkova J; Tomana M; Smith PD; Mestecky J; Renfrow MB; Novak J
    J Biol Chem; 2010 Jul; 285(27):20860-9. PubMed ID: 20439465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.